Stocks  /  NASDAQ  /  Parabilis Medicines Inc.

Parabilis Medicines Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   PBLS – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Parabilis Medicines, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated on its website that it uses animals for drug testing.

“Additionally, we are collecting and leveraging AI and data science for vast multi-modal datasets, including -omics and imaging data from both patient-derived xenograft (PDX) models and patient samples.” Read the following article

Company Description

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Company Website: https://parabilismed.com

Contact:  info@parabilismed.com
Scroll to Top